With this notice, Frontiers states its awareness of serious allegations surrounding the institutional review board Centro Internacional de Vacunas cited in this article. These allegations are being investigated in line with COPE guidelines. The situation will be updated as soon as the investigation is complete.
. 2023 Sep 15;14:1292353. doi: 10.3389/fimmu.2023.1292353
Expression of concern on: A SARS–CoV-2 spike receptor binding motif peptide induces anti-spike antibodies in mice andIs recognized by COVID-19 patients
Frontiers Editorial Office*
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Received 2023 Sep 11; Accepted 2023 Sep 11; Collection date 2023.
Copyright © 2023 Frontiers Editorial Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC10541967 PMID: 37786613
This is an expression of concern about the following article: "A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients" in volume 13, 879946.